Mitsubishi UFJ Trust & Banking
ONC

Mitsubishi UFJ Trust & Banking’s BeOne Medicines Ltd ONC Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.16M Buy
7,573
+6,863
+967% +$2.02M ﹤0.01% 701
2026
Q1 		$211K Sell
710
-2,846
-80% -$921K ﹤0.01% 1057
2025
Q4 		$1.08M Buy
3,556
+1,561
+78% +$511K ﹤0.01% 882
2025
Q3 		$680K Buy
1,995
+387
+24% +$118K ﹤0.01% 946
2025
Q2 		$389K Sell
1,608
-77,269
-98% -$18.9M ﹤0.01% 925
2025
Q1 		$21.5M Sell
78,877
-2,742
-3% -$641K 0.06% 356
2024
Q4 		$15.1M Sell
81,619
-1,844
-2% -$377K 0.04% 466
2024
Q3 		$18.7M Sell
83,463
-2,951
-3% -$531K 0.04% 410
2024
Q2 		$12.3M Sell
86,414
-8,620
-9% -$1.33M 0.03% 504
2024
Q1 		$14.9M Sell
95,034
-9,770
-9% -$1.57M 0.03% 476
2023
Q4 		$18.9M Sell
104,804
-2,890
-3% -$523K 0.04% 405
2023
Q3 		$19.4M Buy
107,694
+12,910
+14% +$2.55M 0.05% 384
2023
Q2 		$16.9M Sell
94,784
-10,380
-10% -$2.39M 0.04% 434
2023
Q1 		$22.7M Sell
105,164
-15,714
-13% -$3.77M 0.06% 355
2022
Q4 		$26.6M Sell
120,878
-2,080
-2% -$381K 0.07% 314
2022
Q3 		$16.6M Buy
122,958
+693
+0.6% +$119K 0.05% 398
2022
Q2 		$19.8M Sell
122,265
-4,917
-4% -$768K 0.05% 375
2022
Q1 		$24M Sell
127,182
-8,392
-6% -$1.78M 0.05% 349
2021
Q4 		$36.7M Sell
135,574
-9,909
-7% -$3.35M 0.08% 274
2021
Q3 		$52.8M Sell
145,483
-11,078
-7% -$3.62M 0.11% 205
2021
Q2 		$53.7M Sell
156,561
-11,135
-7% -$3.69M 0.11% 212
2021
Q1 		$58.4M Sell
167,696
-6,608
-4% -$2.19M 0.13% 202
2020
Q4 		$45M Buy
174,304
+100,579
+136% +$27.7M 0.09% 252
2020
Q3 		$21.1M Buy
73,725
+35,981
+95% +$8.46M 0.05% 382
2020
Q2 		$7.11M Buy
37,744
+8,301
+28% +$1.35M 0.02% 632
2020
Q1 		$3.63M Buy
29,443
+3,002
+11% +$469K 0.01% 703
2019
Q4 		$4.38M Buy
26,441
+122
+0.5% +$20.3K 0.01% 750
2019
Q3 		$3.22M Sell
26,319
-1,006
-4% -$134K 0.01% 768
2019
Q2 		$3.39M Buy
27,325
+3,026
+12% +$384K 0.01% 704
2019
Q1 		$3.21M Sell
24,299
-428
-2% -$57.7K 0.01% 687
2018
Q4 		$3.47M Buy
+24,727
New +$3.28M 0.01% 664

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's ONC Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking increased its BeOne Medicines Ltd (ONC) stake by 967% in Q2 2026, buying an estimated $2.02M and bringing the position to 7,573 shares worth $2.16M. The position accounts for ﹤0.01% of the portfolio, ranked #701.

Mitsubishi UFJ Trust & Banking first reported a position in ONC in Q4 2018 and has held it in 31 quarters since. The position peaked at $58.4M in Q1 2021. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Mitsubishi UFJ Trust & Banking held 7,573 shares of BeOne Medicines Ltd worth $2.16M as of Q2 2026.
  • Mitsubishi UFJ Trust & Banking bought 6,863 BeOne Medicines Ltd shares in Q2 2026, an estimated $2.02M.
  • BeOne Medicines Ltd made up ﹤0.01% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #701 holding.
  • Mitsubishi UFJ Trust & Banking first reported a position in BeOne Medicines Ltd in Q4 2018 and has held it in 31 quarters since.
  • Mitsubishi UFJ Trust & Banking's BeOne Medicines Ltd position peaked at $58.4M in Q1 2021.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.